X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/biosplice-searches-for-a-path-forward-after-osteoarthritis-drug-fails-late-stage-study/
https://www.globenewswire.com/news-release/2024/04/18/2865193/0/en/Biosplice-Announces-Upcoming-Presentation-of-Successful-OA-07-Phase-3-Long-Term-Structure-and-Pain-Function-Results-for-Lorecivivint-for-Treatment-of-Knee-Osteoarthritis-at-OARSI-C.html
https://www.globenewswire.com/news-release/2024/03/08/2843282/0/en/Biosplice-Therapeutics-Announces-Department-of-Defense-DoD-Award-to-Fund-Collaboration-with-The-Roskamp-Institute-to-Advance-its-Neurology-Program.html
https://www.globenewswire.com/news-release/2022/12/15/2574660/0/en/Biosplice-Announces-Interim-Data-from-Phase-3-Long-Term-Extension-Clinical-Trial-in-Knee-Osteoarthritis-and-the-Initiation-of-a-New-Phase-3-Trial.html
https://www.globenewswire.com/news-release/2022/11/11/2554264/0/en/Biosplice-Announces-Data-from-Recent-Clinical-Trials-in-Knee-Osteoarthritis-and-the-Initiation-of-a-New-Phase-3-Trial.html
https://www.globenewswire.com/news-release/2022/09/29/2525253/0/en/Biosplice-Therapeutics-Announced-New-Clinical-Data-for-Cirtuvivint-SM08502-at-the-European-Society-for-Clinical-Oncology-Meeting.html
https://www.fiercebiotech.com/biotech/biosplice-lays-off-41-drops-baldness-program-as-12b-valuation-confuses-everyone
https://www.globenewswire.com/news-release/2021/11/17/2336513/0/en/First-Subject-Dosed-in-Biosplice-Therapeutics-Phase-1b-Clinical-Trial-in-Oncology.html
https://www.globenewswire.com/news-release/2021/09/15/2297627/0/en/Biosplice-Licenses-Development-and-Commercialization-Rights-for-Lorecivivint-a-Novel-Phase-3-Osteoarthritis-Drug-Candidate-to-Haisco-for-the-People-s-Republic-of-China.html
Market Place
Share 
